INFDIS

Pfizer CEO rules out generic COVID drug Paxlovid for China

by

Jan. 9 (Reuters) – Pfizer Inc (PFE.N) It’s not in talks with Chinese authorities to license a generic version of its COVID-19 treatment Paxlovid for use there, CEO Albert Bourla said Monday, but it is in discussions about the price of the branded product. Reuters reported on Friday that China is in talks with Pfizer … Read more

China vows ‘final victory’ over Covid as the outbreak worries the world

by

The virus is spreading rapidly in China after the policy change The latest country in Japan to require tests from China arrivals European Union meeting to discuss Chinese travel policy WHO seeks data from Chinese scientists BEIJING (Reuters) – Global health officials struggled to establish the realities of the novel coronavirus outbreak in China and … Read more